Rivernorth Capital Management’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-75,650
| Closed | -$758K | – | 796 |
|
|
2022
Q3 | $758K | Hold |
75,650
| – | – | 0.03% | 422 |
|
|
2022
Q2 | $759K | Hold |
75,650
| – | – | 0.03% | 406 |
|
|
2022
Q1 | $747K | Buy |
+75,650
| New | +$747K | 0.03% | 426 |
|
|
2021
Q1 | – | Sell |
-100,000
| Closed | -$1.07M | – | 516 |
|
|
2020
Q4 | $1.07M | Buy |
+100,000
| New | +$1.07M | 0.06% | 181 |
|